U-NEXT HOLDINGS Co.,Ltd. (TYO:9418)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	58,499	52,738	52,132	26,390	21,585	16,785
Cash & Short-Term Investments	58,499	52,738	52,132	26,390	21,585	16,785
Cash Growth	6.84%	1.16%	97.55%	22.26%	28.60%	-18.37%
Receivables	40,844	40,859	31,002	24,952	20,531	18,744
Inventory	13,034	11,302	9,708	7,808	6,874	6,417
Prepaid Expenses	46,922	40,694	24,364	13,528	9,034	-
Other Current Assets	5,180	4,625	4,019	2,673	2,668	7,363
Total Current Assets	164,479	150,218	121,225	75,351	60,692	49,309
Property, Plant & Equipment	24,815	21,056	18,419	19,143	19,197	21,109
Long-Term Investments	-	-303	-682	-964	-1,191	-1,622
Goodwill	40,883	39,490	42,591	44,324	47,322	50,620
Other Intangible Assets	12,844	7,704	6,084	5,463	5,103	4,413
Long-Term Deferred Tax Assets	-	5,489	7,584	4,497	5,204	9,594
Other Long-Term Assets	9,696	3	1	1	2	3
Total Assets	252,717	228,962	200,524	153,007	141,316	138,374
Accounts Payable	34,462	33,686	26,466	23,496	19,254	18,316
Current Portion of Long-Term Debt	3,153	3,066	3,000	5,450	4,580	6,060
Current Income Taxes Payable	5,010	6,392	2,460	3,600	-	-
Other Current Liabilities	34,140	28,385	23,601	19,211	17,008	16,610
Total Current Liabilities	76,765	71,529	55,527	51,757	40,842	40,986
Long-Term Debt	66,451	59,822	60,970	53,970	59,430	64,120
Other Long-Term Liabilities	3,588	3,332	3,981	4,652	5,365	4,373
Total Liabilities	148,975	136,929	122,818	112,727	107,982	112,632
Common Stock	99	99	97	96	96	95
Additional Paid-In Capital	29,786	29,786	29,784	11,092	11,091	11,090
Retained Earnings	62,707	51,843	38,138	28,763	21,877	14,313
Comprehensive Income & Other	165	139	432	327	267	233
Total Common Equity	92,757	81,867	68,451	40,278	33,331	25,731
Minority Interest	10,985	10,166	9,255	2	3	11
Shareholders' Equity	103,742	92,033	77,706	40,280	33,334	25,742
Total Liabilities & Equity	252,717	228,962	200,524	153,007	141,316	138,374
Total Debt	69,604	62,888	63,970	59,420	64,010	70,180
Net Cash (Debt)	-11,105	-10,150	-11,838	-33,030	-42,425	-53,395
Net Cash Per Share	-61.57	-56.28	-65.91	-183.12	-235.21	-296.05
Filing Date Shares Outstanding	180.37	180.38	180.33	180.27	180.25	180.22
Total Common Shares Outstanding	180.37	180.38	180.29	180.27	180.25	180.22
Working Capital	87,714	78,689	65,698	23,594	19,850	8,323
Book Value Per Share	514.25	453.87	379.67	223.44	184.92	142.78
Tangible Book Value	39,030	34,673	19,776	-9,509	-19,094	-29,302
Tangible Book Value Per Share	216.38	192.23	109.69	-52.75	-105.93	-162.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.